For the third day in a row, the US saw a daily increase in COVID-19 cases

The Baltimore-based University added that it will be open until Friday at 8 p.m. 30 minutes. 1,149 people previously infected with coronavirus died at local time (Saturday, 3:30 am Lithuania).

The COVID-19 epidemic has spread in the country for several weeks. The worst situation is now in the Midwest, but the number of new infections detected per day in the south, northeast and west of the country is approaching the level seen during the first wave of COVID-19 in the spring.

So far, mortality remains much lower than in the spring, but Friday was the fourth consecutive day that more than a thousand people died daily. The last mortality at this level for COVID-19 patients in the United States was observed in early September.

By Friday night, more than 236,000 people had been diagnosed in the United States, the country hardest hit by the coronavirus pandemic, both in terms of total deaths and infection rates. coronavirus-related deaths and 9.7 million COVID-19 cases.

Morbidity is likely to increase further as the weather cools and people become more exposed indoors. These conditions are the most favorable for the spread of the virus.

Cooler, drier air can also create favorable conditions for greater survival in air and on surfaces.

The likely reason for the lower-than-observed spring mortality is that the epidemic is now geographically distributed more evenly across the United States, allowing hospitals to cope with patient workloads.

In addition, doctors have also learned to better treat severe cases of COVID-19: patients lie on their stomach; whenever possible, efforts should be made not to use artificial lung ventilators or to use lower pressures when necessary. Perhaps most importantly, patients are now on steroids like dexamethasone to suppress an overly stormy autoimmune response called a cytokine storm.

Now, most of those infected are younger people, who are less likely to develop a serious illness.

The vaccine makers Moderna and Pfizer have indicated that they may be ready to apply for approval of their formulations by the end of November for use in emergencies.

However, once vaccines are available, they are likely to be only moderately effective, so people will continue to need to wear masks, distance, and hand hygiene to end the pandemic.